Laekna Limited
Clinical trials sponsored by Laekna Limited, explained in plain language.
-
New weight management drug enters first human testing
Disease control Recruiting nowThis early-stage study aims to test the safety and how the body processes a new injection called LAE102. It will involve 160 healthy and overweight volunteers to see how well they tolerate different doses. The research will also gather initial information on whether the injection…
Phase: PHASE1 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Early test of potential new obesity shots begins
Disease control Recruiting nowThis early-stage study is checking the safety and how the body processes two new injectable drugs, LAE103 and LAE102, in healthy overweight or obese adults and postmenopausal women. Researchers will give single and multiple doses to about 104 participants to see how well they are…
Phase: PHASE1 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough breast cancers: testing a promising drug duo
Disease control Recruiting nowThis study is testing whether adding an experimental drug called afuresertib to the standard hormone therapy fulvestrant can better control advanced breast cancer that has grown despite prior treatments. It is for adults with a specific type of breast cancer (HR+/HER2-) that has …
Phase: PHASE3 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC